Literature DB >> 34665436

Identifying women with increased risk of breast cancer and implementing risk-reducing strategies and supplemental imaging.

Suneela Vegunta1, Asha A Bhatt2, Sadia A Choudhery2, Sandhya Pruthi3, Aparna S Kaur3.   

Abstract

Breast cancer (BC) is the second most common cancer in women, affecting 1 in 8 women in the United States (12.5%) in their lifetime. However, some women have a higher lifetime risk of BC because of genetic and lifestyle factors, mammographic breast density, and reproductive and hormonal factors. Because BC risk is variable, screening and prevention strategies should be individualized after considering patient-specific risk factors. Thus, health care professionals need to be able to assess risk profiles, identify high-risk women, and individualize screening and prevention strategies through a shared decision-making process. In this article, we review the risk factors for BC, risk-assessment models that identify high-risk patients, and preventive medications and lifestyle modifications that may decrease risk. We also discuss the benefits and limitations of various supplemental screening methods.
© 2021. The Author(s), under exclusive licence to The Japanese Breast Cancer Society.

Entities:  

Keywords:  BRCA; Breast MRI; Dense breast tissue; Risk factors for breast cancer; Risk-assessment models

Mesh:

Year:  2021        PMID: 34665436     DOI: 10.1007/s12282-021-01298-x

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  76 in total

1.  Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Heidi D Nelson; Miranda Pappas; Amy Cantor; Elizabeth Haney; Rebecca Holmes
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

Review 2.  Benign Breast Disease in Women.

Authors:  Angrit Stachs; Johannes Stubert; Toralf Reimer; Steffi Hartmann
Journal:  Dtsch Arztebl Int       Date:  2019-08-09       Impact factor: 5.594

3.  US Preventive Services Task Force Breast Cancer Recommendation Statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer.

Authors:  Lisa Newman
Journal:  JAMA Surg       Date:  2019-10-01       Impact factor: 14.766

4.  Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy.

Authors:  Lin-Ying Chen; Jintao Hu; Julia Y S Tsang; Michelle A Lee; Yun-Bi Ni; Siu-Ki Chan; Gary M K Tse
Journal:  Histopathology       Date:  2019-07-16       Impact factor: 5.087

Review 5.  The woman at increased risk for breast cancer: evaluation and management strategies.

Authors:  M M Bilimoria; M Morrow
Journal:  CA Cancer J Clin       Date:  1995 Sep-Oct       Impact factor: 508.702

6.  Two decades after BRCA: setting paradigms in personalized cancer care and prevention.

Authors:  Fergus J Couch; Katherine L Nathanson; Kenneth Offit
Journal:  Science       Date:  2014-03-28       Impact factor: 47.728

Review 7.  The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer.

Authors:  Lisa A Newman; Jorge S Reis-Filho; Monica Morrow; Lisa A Carey; Tari A King
Journal:  Ann Surg Oncol       Date:  2014-12-20       Impact factor: 5.344

8.  Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.

Authors:  Melissa K Frey; Rohini V Kopparam; Zhen Ni Zhou; Jessica C Fields; Ama Buskwofie; Ann D Carlson; Thomas Caputo; Kevin Holcomb; Eloise Chapman-Davis
Journal:  Cancer       Date:  2018-11-27       Impact factor: 6.860

Review 9.  Advances in breast cancer: pathways to personalized medicine.

Authors:  Olufunmilayo I Olopade; Tatyana A Grushko; Rita Nanda; Dezheng Huo
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

10.  Trends in breast cancer mortality by stage at diagnosis among young women in the United States.

Authors:  Fangjian Guo; Yong-Fang Kuo; Ya Chen Tina Shih; Sharon H Giordano; Abbey B Berenson
Journal:  Cancer       Date:  2018-09-06       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.